John Paulson, founder of hedge fund firm Paulson & Co., said corporate merger and acquisition activity “will continue for the foreseeable future.”

We will be covering the conference – sign up for our newsletter to ensure you get all the updates.

John Paulson

John Paulson: M&A activity to continue for foreseeable future

John Paulson on Allergan as Valeant takeover target

John Paulson, founder of hedge fund firm Paulson & Co., said Allergan, Inc. (NYSE:AGN) shares could be worth $222 a share as a result of a potential takeover by Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX).